February 4, 2012
| Bio-IT World > Gilna to Captain CAMERA


Gilna to Captain CAMERA



Later this summer, coinciding with the publication of the first peer-reviewed paper on results from J. Craig Venter’s worldwide voyage sampling ocean genomes, researchers will gain access to version 0.5 of CAMERA—the Community Cyberinfrastructure for Advanced Marine Microbial Ecology Research and Analysis—a platform replete with a wealth of data, analysis tools, and high-speed computational infrastructure.

“We’ll point readers to the portal from the paper,” says Paul Gilna, who was appointed executive director of CAMERA last month. Gilna is an experienced science program administrator who helped launch GenBank, worked on the protein data bank (PDB), and was a director of DOE’s Joint Genome Institute at Los Alamos National Laboratory. He hopes CAMERA will help jumpstart and grow the nascent field of metagenomics.

“I’ve noticed it’s one of those fields that’s beginning to take on the ‘in-the-eye-of-the-beholder definition,’ says Gilna. Broadly, metagenomics has been used two ways: One refers to the sequencing of microbial communities that contain large mixtures of microbial species; the other is the capture of data associated with any given microbe or microbial sequence or microbial genome. CAMERA will emphasize the latter, says Gilna, as pure sequence data will also submitted to GenBank, but its metadata will also be housed at CAMERA.

“When we lift a sample out of soils or out of the ocean, we know we are sequencing parts of many thousands, even millions of microbes,” Gilna says. “So for any one sequence, getting the context of what was around it at the time in terms of other sequences is important. In the case of genome sequences garnered from the ocean surveys, there is information associated with spatial location such as GPS coordinates as well as satellite imagery of the particular sites. There are data associated with ocean conditions such as depth, temperature, salinity.”

Soon, scientists may have those data at their finger tips. CAMERA is a partnership among the J. Craig Venter Institute (JCVI), the California Institute for Telecommunications and Information Technology (Calit2), UCSD’s Center for Earth Observation and Applications based at the Scripps Institution of Oceanography, and the San Diego Supercomputer Center.

JCVI is providing data and analysis and visualization tools. Calit2 is providing computational infrastructure, based on its high-performance optical networked computing system known as OptIPuter (which is building on a national high-speed 10-gigabit grid). Funding of $24.5 million, over seven years, comes from the Gordon and Betty Moore Foundation, which also partly funded Venter’s ocean genome sampling project.

“Phase one, which we sort of term the sprint phase, is to really get the system up and running, knowing what we do today. The second phase, which we’ve characterized as the marathon, is one in which the facilities we offer, the tools that we offer, will in large part be defined by the community itself. We know our assembled partnership here can say and posit a lot of what could be done to harness this new data set, but part of what we need to do is engage with the community,” says Gilna.

In fact, a key CAMERA goal, says its new boss, is to create a platform on which members of the community can not only develop needed tools but also use that same platform to provide them to the community at large.

The project began in earnest in February, and Gilna says a series of release cycles has already been planned. Roughly 30 people are working full time at JCVI on the project, and a similar number in San Diego are engaged in the day-to-day project management of getting the first release in place to coincide with publication of the papers. Gilna didn’t specify which journal, but said the June-July timeframe was likely.

“If you look at GenBank, which is where I really started this career, I came to Los Alamos in 1988 to join the project. The growth of data at the time had clearly begun to demonstrate an exponential growth pattern, when in fact at the project’s initiation everybody believed, certainly the funders, that the growth rate would at best be linear,” says Gilna.

He expects CAMERA to experience the same sort of explosive data influx and to produce a great deal of fundamental science such as was hinted at by the Venter proof-of-concept sequencing effort in the Sargasso Sea in which he reported finding 70,000 entirely novel genes, from an estimated 1,800 genomic species, including 148 novel bacterial phylotypes (see Venter Makes Waves—Again, April 2004 Bio-IT World, page 1).

Turning the bicoastal effort into a cohesive team will require both advanced technology (“state-of-the-art videoconferencing”) and surmounting cultural challenges, agrees Gilna, whose “line of sight” bosses include Larry Smarr, director of Calit2, and Ramesh Rao, USCD division director of Calit2. No doubt Venter will share his opinions with the new director.

“This is a huge and welcome challenge for me,” says Gilna. “I’ve sort of known these people throughout my career in one way or another. I’m most energized when I’m working on projects where success or failure is judged by how well the community believes it has been served.” If the past is prologue, CAMERA is likely in good hands.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 





For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .